Canopy Growth (CGC) Receives a Sell from ATB Capital Markets
ATB Capital Markets analyst maintained a Sell rating on Canopy Growth today and set a price target of C$1.40.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
In addition to ATB Capital Markets, Canopy Growth also received a Sell from TipRanks – Anthropic’s Anthropic Drug Manufacturers – Specialty and Generic in a report issued yesterday. However, on the same day, TipRanks – Google reiterated a Hold rating on Canopy Growth (NASDAQ: CGC).
CGC market cap is currently C$550.7M and has a P/E ratio of -0.82.
Based on the recent corporate insider activity of 24 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CGC in relation to earlier this year. Last month, Theresa Yanofsky, a Director at CGC sold 10,434.00 shares for a total of $11,790.42.
Read More on CGC:
Disclaimer & DisclosureReport an Issue
- Canopy Growth Faces Downside Risk if Uncertain MTL Deal Fails to Close, Analyst Warns
- Canopy Growth price target lowered to C$1.80 from C$2.50 at Alliance Global
- Canopy Growth files to sell 18.71M common shares for holders
- Largest borrow rate increases among liquid names
- Canopy Growth Narrows Losses and Bolsters Balance Sheet as Canadian Cannabis Sales Rise
